Nucleic acid linked immune-sandwich assay (nulisa)
AssigneeAlamar Biosciences, Inc.
InventorsYuling Luo, Wei Feng, Adrian Grzybowski, Yiyuan Yin, Shiping Chen
Life of this patent
Estimating the term…
Abstract
Disclosed herein are highly sensitive immunoassays that utilize a capture/release mechanism to reduce non-specific binding and achieve detection with attomolar-level sensitivity. Kits that can be used for carrying out these highly sensitive immunoassays are also disclosed herein.
Claims31
1-284. (canceled)
An assay method for detecting an analyte in a sample, comprising:
- (1) mixing a first binding moiety and a second binding moiety and the sample in a solution, wherein:
- (i) the first binding moiety comprises a first antibody or a first antibody fragment that specifically binds the analyte, a first nucleic acid tag that comprises a poly-A or poly-T sequence and is conjugated to the first antibody or the first antibody fragment, and a first nucleic acid target label that hybridizes with the first nucleic acid tag;
- (ii) the second binding moiety comprises a second antibody or a second antibody fragment that specifically binds the analyte, a second nucleic acid tag that comprises a second nucleic acid target label and is conjugated to the second antibody or the second antibody fragment, and a nucleic acid probe that is conjugated with biotin and hybridizes with the second nucleic acid tag;
- and
- (iii) the first antibody or the first antibody fragment and the second antibody or the second antibody fragment bind to the analyte and form an immunocomplex;
- (2) introducing first paramagnetic beads coupled with a poly-T or poly-A sequence and capturing the immunocomplex on the first paramagnetic beads by hybridization between the poly-A sequence from the first binding moiety and the poly-T sequence from the first paramagnetic beads, or between the poly-T sequence from the first binding moiety and the poly-A sequence from the first paramagnetic beads;
- (3) washing the first paramagnetic beads to remove unbound molecules;
- (4) releasing the immunocomplex from the first paramagnetic beads to the solution by disrupting the hybridization between the poly-A sequence from the first binding moiety and the poly-T sequence from the first paramagnetic beads, or between the poly-T sequence from the first binding moiety and the poly-A sequence from the first paramagnetic beads;
- (5) introducing second paramagnetic beads coupled with streptavidin and recapturing the immunocomplex on the second paramagnetic beads via binding between the biotin from the second binding moiety and the streptavidin from the second paramagnetic beads;
- (6) washing the second paramagnetic beads to remove unbound molecules;
- (7) introducing to a solution containing the second paramagnetic beads a single-stranded nucleic acid connector that comprises a first segment hybridizing with the first nucleic acid target label, and a neighboring second segment hybridizing with the second nucleic acid target label, and completing proximity-based ligation between the first and second nucleic acid target labels following hybridization between the single-stranded nucleic acid connector and the first and second nucleic acid target labels in the immunocomplex to generate a nucleic acid reporter that bridges the first and second nucleic acid target labels;
- and
- (8) detecting the nucleic acid reporter, thereby detecting the analyte.
An assay method for detecting an analyte in at least two samples, comprising:
- (1) mixing a first binding moiety and a second binding moiety and the sample in a solution, wherein:
- (i) the first binding moiety comprises a first antibody or a first antibody fragment that specifically binds the analyte, a first nucleic acid tag that comprises a poly-A or poly-T sequence and is conjugated to the first antibody or the first antibody fragment, and a first nucleic acid target label that comprises a first identity barcode (“ID”) that is analyte-specific (“target ID”) and hybridizes with the first nucleic acid tag;
- (ii) the second binding moiety comprises a second antibody or a second antibody fragment that specifically binds the analyte, a second nucleic acid tag that comprises a second nucleic acid target label and is conjugated to the second antibody or the second antibody fragment, wherein the second nucleic acid target label comprises a second target ID that is analyte-specific, and a nucleic acid probe that is conjugated with biotin and hybridizes with the second nucleic acid tag;
- and
- (iii) the first antibody or the first antibody fragment and the second antibody or the second antibody fragment bind to the analyte and form an immunocomplex;
- (2) introducing first paramagnetic beads coupled with a poly-T or poly-A sequence and capturing the immunocomplex on the first paramagnetic beads by hybridization between the poly-A sequence from the first binding moiety and the poly-T sequence from the first paramagnetic beads, or between the poly-T sequence from the first binding moiety and the poly-A sequence from the first paramagnetic beads;
- (3) washing the first paramagnetic beads to remove unbound molecules;
- (4) releasing the immunocomplex from the first paramagnetic beads to the solution by disrupting the hybridization between the poly-A sequence from the first binding moiety and the poly-T sequence from the first paramagnetic beads, or between the poly-T sequence from the first binding moiety and the poly-A sequence from the first paramagnetic beads;
- (5) introducing second paramagnetic beads coupled with streptavidin and recapturing the immunocomplex on the second paramagnetic beads via binding between the biotin from the second binding moiety and the streptavidin from the second paramagnetic beads;
- (6) washing the second paramagnetic beads to remove unbound molecules;
- (7) introducing a partially double-stranded nucleic acid connector that comprises (i) a longer strand with a 5′ overhang and a 3′ overhang, wherein one of the overhangs hybridizes with the first nucleic acid target label and the other overhang hybridizes with the second nucleic acid target label;
- and (ii) a shorter strand comprising an ID that is sample-specific (“sample ID”);
- and hybridizing the 5′ overhang and the 3′ overhang of the partially double-stranded nucleic acid connector to the first nucleic acid target label and the second nucleic acid target label, and completing proximity-based ligation between (i) the first nucleic acid target label and the sample label and (ii) the second nucleic acid target label and sample label, to generate a nucleic acid reporter that comprises the first target ID, the sample ID, and the second target ID,
- (8) pooling the nucleic acid reporters of at least two samples together;
- and
- (9) detecting the nucleic acid reporter comprising the first target ID, the sample ID, and the second target ID, thereby detecting the analyte.
An assay method for detecting an analyte in a sample, comprising:
- (1) mixing a first binding moiety comprising a first binder and a first presenting group, a second binding moiety comprising a second binder and a second presenting group, and the sample in a solution, wherein:
- (i) the first and second binders bind to the analyte and form an immunocomplex,
- (ii) the immunocomplex is captured on a first solid surface in contact with the solution via binding between the first presenting group and a first receiving group coupled to the first solid surface,
- (iii) the first binding moiety further comprises a first target label and the second binding moiety further comprises a second target label, and
- (iv) wherein the first binder is an antibody or an antibody fragment that specifically binds the analyte and the second binder is an antibody or an antibody fragment that specifically binds the analyte;
- (2) washing the first solid surface to remove unbound molecules;
- (3) releasing the immunocomplex from the first solid surface by disrupting the binding between the first presenting group and the first receiving group;
- (4) introducing a second solid surface and recapturing the immunocomplex on the second solid surface via binding between the second presenting group and the second receiving group coupled to the second solid surface;
- (5) washing the second solid surface to remove unbound molecules;
- (6) binding a connector to both the first target label and the second target label;
- (7) generating a nucleic acid reporter from the immunocomplex by proximity-based ligation between the first target label and the second target label;
- and
- (8) detecting the nucleic acid reporter, thereby detecting the analyte.
An assay method for detecting an analyte in at least two samples, comprising:
- (1) mixing a first binding moiety comprising a first binder and a first presenting group, a second binding moiety comprising a second binder and a second presenting group, and the samples in a solution, wherein:
- (i) the first and second binders bind to the analyte and form an immunocomplex,
- (ii) the immunocomplex is captured on a first solid surface in contact with the solution via binding between the first presenting group and a first receiving group coupled to the first solid surface,
- (iii) the first binding moiety further comprises a first target label comprising a first identity barcode (“ID”) that is analyte-specific (“target ID”) and the second binding moiety further comprises a second target label comprising a second target ID, and
- (iv) wherein the first binder is an antibody or an antibody fragment that specifically binds the analyte and the second binder is an antibody or an antibody fragment that specifically binds the analyte;
- (2) washing the first solid surface to remove unbound molecules;
- (3) releasing the immunocomplex from the first solid surface by disrupting the binding between the first presenting group and the first receiving group;
- (4) introducing a second solid surface and recapturing the immunocomplex on the second solid surface via binding between the second presenting group and the second receiving group coupled to the second solid surface;
- (5) washing the second solid surface to remove unbound molecules;
- (6) binding a sample label comprising an ID that is sample-specific (“sample ID”) (i) to the first target label, (ii) to the second target label, or (iii) to both the first target label and the second target label;
- (7) generating a nucleic acid reporter from the immunocomplex by proximity-based ligation between (i) the first target label and the sample label and (ii) the second target label and sample label, wherein the nucleic acid reporter comprises the first target ID, the second target ID, and the sample ID;
- (8) pooling the nucleic acid reporters from the at least two samples;
- and
- (9) detecting the nucleic acid reporters, thereby detecting the analyte.
Dependencies are inferred from the claim text.